Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways

Emerging coronaviruses (CoVs) primarily cause severe gastroenteric or respiratory diseases in humans and animals, and no approved therapeutics are currently available. Here, A9, a receptor tyrosine kinase inhibitor (RTKI) of the tyrphostin class, is identified as a robust inhibitor of transmissible...

全面介紹

Na minha lista:
書目詳細資料
發表在:Antiviral Res
Main Authors: Dong, Wanyu, Xie, Wenting, Liu, Yunbo, Sui, Baokun, Zhang, Hao, Liu, Liran, Tan, Yubei, Tong, Xiaohan, Fu, Zhen F., Yin, Ping, Fang, Liurong, Peng, Guiqing
格式: Artigo
語言:Inglês
出版: Published by Elsevier B.V. 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114126/
https://ncbi.nlm.nih.gov/pubmed/31751591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2019.104651
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍